Omega Diagnostics Group Plc (LON:ODX)‘s stock had its “corporate” rating reaffirmed by stock analysts at FinnCap in a report released on Monday. They presently have a GBX 28 ($0.35) target price on the stock. FinnCap’s target price suggests a potential upside of 53.42% from the company’s previous close.

Omega Diagnostics Group Plc (LON:ODX) opened at 19.00 on Monday. The company’s market cap is GBX 20.66 million. The firm’s 50-day moving average price is GBX 16.89 and its 200-day moving average price is GBX 16.74. Omega Diagnostics Group Plc has a one year low of GBX 13.50 and a one year high of GBX 21.00.

Omega Diagnostics Group Plc Company Profile

Omega Diagnostics Group PLC, based in the United Kingdom, is a holding company. The Company, along with its subsidiaries is engaged in manufacture, development and distribution of medical diagnostics products. The Company operates in three segments: Allergy and Autoimmune, Food Intolerance and Infectious Disease and Other.

Receive News & Ratings for Omega Diagnostics Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Diagnostics Group Plc and related companies with's FREE daily email newsletter.